| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 1984 | 2006 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 1985 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.100 | None | 0.962 | 1 | 0 | 1987 | 2019 | ||||||||
|
carbonic anhydrase 9 | 0.483 | 0.731 | 1.3E-09 |
|
disease | 0.100 | None | 1.000 | 2 | 0 | 1988 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.100 | None | 0.952 | 1 | 0 | 1988 | 2019 | ||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
disease | 0.700 | strong | 0.970 | 20 | 0 | 1989 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.400 | None | 0.966 | 2 | 0 | 1989 | 2019 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1990 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.500 | None | 0.900 | 3 | 0 | 1991 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 1991 | 2019 | ||||||||
|
insulin like growth factor binding protein 3 | 0.439 | 0.808 | 0.91 |
|
disease | 0.080 | None | 0.875 | 2 | 0 | 1991 | 2017 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.100 | None | 1.000 | 4 | 0 | 1992 | 2019 | ||||||||
|
beta-2-microglobulin | 0.447 | 0.846 | 0.56 |
|
disease | 0.070 | None | 1.000 | 1 | 0 | 1992 | 2007 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1992 | 2020 | ||||||||
|
platelet derived growth factor subunit A | 0.533 | 0.731 | 0.81 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 1993 | 2008 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.100 | None | 0.973 | 4 | 0 | 1994 | 2020 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 2 | 0 | 1994 | 2019 | ||||||||
|
erythropoietin | 0.381 | 0.885 | 1.1E-02 |
|
disease | 0.100 | None | 0.909 | 1 | 0 | 1994 | 2016 | ||||||||
|
paired box 2 | 0.495 | 0.731 | 0.67 |
|
disease | 0.100 | None | 0.923 | 3 | 0 | 1995 | 2013 | ||||||||
|
MOK protein kinase | 0.476 | 0.769 | 8.8E-22 |
|
disease | 0.040 | None | 1.000 | 2 | 0 | 1996 | 2018 | ||||||||
|
transcription factor binding to IGHM enhancer 3 | 0.542 | 0.654 | 0.98 |
|
disease | 0.500 | None | 0.983 | 2 | 0 | 1996 | 2020 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.400 | None | 0.953 | 2 | 0 | 1996 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.100 | None | 0.970 | 2 | 0 | 1996 | 2019 | ||||||||
|
retinoic acid receptor beta | 0.478 | 0.846 | 1.00 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 1996 | 2005 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
disease | 0.070 | None | 0.857 | 1 | 0 | 1996 | 2020 |